Table 1 Inhibitors used in this study.
From: Evaluation of signal transduction pathways after transient cutaneous adenoviral gene delivery
Bay11-7085 | nuclear factor κB (NFkB) |
|---|---|
PD 98,059 | extracellular regulated kinase 2 (Erk2); mitogen-activated protein kinase kinase (MAPKK) |
SB203580 | p38 mitogen-activated protein kinase (p38 MAPK) |
LY294,002 | phosphoinositid-3-kinase (PI3K) |
Tyrphostin AG 490 | januskinase/signal transductor and aktivator of transcription (JAK/STAT) |
SP600125 | c-Jun N-terminal kinase (JNK) |